ATAI Life Sciences N.V (NASDAQ: ATAI) is 5.67% higher on its value in year-to-date trading and has touched a low of $1.03 and a high of $2.85 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The ATAI stock was last observed hovering at around $1.60 in the last trading session, with the day’s loss setting it -0.11%.
Currently trading at $1.49, the stock is -5.52% and 13.19% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.6 million and changing -6.88% at the moment leaves the stock -3.80% off its SMA200. ATAI registered 33.04% gain for a year compared to 6-month loss of 0.68%. The firm has a 50-day simple moving average (SMA 50) of $1.3102 and a 200-day simple moving average (SMA200) of $1.55075.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 37.96% gain in the last 1 month and extending the period to 3 months gives it a 25.21%, and is -13.87% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 7.48% over the week and 12.92% over the month.
ATAI Life Sciences N.V (ATAI) has around 83 employees, a market worth around $250.02M and $0.33M in sales. Profit margin for the company is -38852.87%. Distance from 52-week low is 44.66% and -47.72% from its 52-week high. The company has generated returns on investments over the last 12 months (-77.07%).
The EPS is expected to shrink by -217.14% this year
104.0 institutions hold shares in ATAI Life Sciences N.V (ATAI), with institutional investors hold 29.74% of the company’s shares. The shares outstanding are 167.82M, and float is at 117.06M with Short Float at 8.44%. Institutions hold 26.77% of the Float.
The top institutional shareholder in the company is WALLEYE CAPITAL LLC with over 2.76 million shares valued at $3.67 million. The investor’s holdings represent 1.7388 of the ATAI Shares outstanding. As of 2024-06-30, the second largest holder is MORGAN STANLEY with 2.72 million shares valued at $3.62 million to account for 1.7111 of the shares outstanding. The other top investors are BLACKROCK INC. which holds 1.31 million shares representing 0.8225 and valued at over $1.74 million, while BROWN UNIVERSITY holds 0.4522 of the shares totaling 0.72 million with a market value of $0.96 million.
ATAI Life Sciences N.V (ATAI) Insider Activity
The most recent transaction is an insider sale by ATAI Life Sciences N.V., the company’s 10% Owner. SEC filings show that ATAI Life Sciences N.V. sold 2,660,000 shares of the company’s common stock on Sep 26 ’24 at a price of $6.05 per share for a total of $16.09 million. Following the sale, the insider now owns 6.91 million shares.
ATAI Life Sciences N.V disclosed in a document filed with the SEC on May 16 ’24 that Brand Florian () sold a total of 151,303 shares of the company’s common stock. The trade occurred on May 16 ’24 and was made at $1.92 per share for $0.29 million. Following the transaction, the insider now directly holds 0.33 million shares of the ATAI stock.
Still, SEC filings show that on Apr 02 ’24, Johnson Anne Nagengast (Chief Financial Officer) disposed off 27,410 shares at an average price of $1.85 for $50708.0. The insider now directly holds 73,590 shares of ATAI Life Sciences N.V (ATAI).
